SPOTLIGHT: Comparison of zolbetuximab or placebo+mFOLFOX6 as first-line treatment in patients with claudin18.2+/HER2-locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (GEJ): A randomized phase III study

被引：0

作者：

Yamaguchi, K. ^{[1
]}

Shitara, K. ^{[2
]}

Al-Batran, S-E. ^{[3
]}

Bang, Y-J. ^{[4
]}

Catenacci, D. ^{[5
]}

Enzinger, P. ^{[6
]}

Ilson, D. ^{[7
]}

Kim, S. ^{[8
]}

Lordick, F. ^{[9
]}

Shah, M. ^{[10
]}

Van Cutsem, E. ^{[11
,12
]}

Xu, R-H. ^{[13
]}

Arozullah, A. ^{[14
]}

Park, J. Wook ^{[14
]}

Ajani, J. ^{[15
]}

机构：

[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Ariake, Japan

[2] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[3] Inst Klin Onkol Forsch, Inst Clin Canc Res, Frankfurt, Germany

[4] Seoul Natl Univ Hosp, Med Oncol, Seoul, South Korea

[5] Univ Chicago, Gastrointestinal Oncol Program, Chicago, IL 60637 USA

[6] Dana Farber Canc Inst, Ctr Esophageal & Gastr Canc, Med Oncol, Boston, MA 02115 USA

[7] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[8] Medstar Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Hematol Oncol, Washington, DC USA

[9] Univ Leipzig, Univ Canc Ctr Leipzig, Leipzig, Germany

[10] Weill Cornell Med Coll, Med Oncol, New York, NY USA

[11] Univ Hosp Gasthuisberg, Digest Oncol, Leuven, Belgium

[12] KULeuven, Leuven, Belgium

[13] Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Guangdong, Peoples R China

[14] Astellas Pharma Global Dev Inc, Northbrook, IL USA

[15] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Div Canc Med, Houston, TX 77030 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

198TiP

引用

页数：2